Blood cell-derived human tissue Transglutaminase (TG2) in multiple sclerosis: -Implications for the pathogenesis and clinical outcome-

C. Sestito

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • Vrije Universiteit, Amsterdam, Netherlands
Supervisors/Advisors
  • Drukarch, Benjamin, Supervisor
  • van Dam, Anne-Marie, Co-supervisor
  • Wilhelmus, Micha, Co-supervisor
Award date31 Oct 2019
Publication statusPublished - 2019

Cite this

@phdthesis{e9011e22a8ba4d2cb05b7c90a972e554,
title = "Blood cell-derived human tissue Transglutaminase (TG2) in multiple sclerosis: -Implications for the pathogenesis and clinical outcome-",
keywords = "Tissue Transglutaminase; neuroinflammation, multiple sclerosis; biomarker",
author = "C. Sestito",
year = "2019",
language = "English",
school = "Vrije Universiteit, Amsterdam, Netherlands",

}

Blood cell-derived human tissue Transglutaminase (TG2) in multiple sclerosis : -Implications for the pathogenesis and clinical outcome-. / Sestito, C.

2019. 133 p.

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

TY - THES

T1 - Blood cell-derived human tissue Transglutaminase (TG2) in multiple sclerosis

T2 - -Implications for the pathogenesis and clinical outcome-

AU - Sestito, C.

PY - 2019

Y1 - 2019

KW - Tissue Transglutaminase; neuroinflammation

KW - multiple sclerosis; biomarker

M3 - Research VU University Amsterdam, graduation VU University Amsterdam

ER -